Published in Arthritis Rheum on March 27, 1972
Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis. Br Med J (1975) 2.91
Rheumatoid arthritis of the robust reaction type. Ann Rheum Dis (1974) 1.32
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol (1974) 1.26
Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis. J Clin Invest (1980) 1.26
Autoantibody profile in juvenile chronic arthritis. Ann Rheum Dis (1988) 1.02
Determination of IgG antiglobulins in rheumatoid disease using insolubilized human IgG. Clin Exp Immunol (1973) 1.01
Laboratory diagnosis of rheumatoid arthritis: a solid phase radioassay for IgG and IgM antiglobulins. J Clin Pathol (1976) 1.01
Antigen-antibody complexes in the serum of patients with juvenile chronic arthritis. Arch Dis Child (1979) 0.96
Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis (1980) 0.93
Impaired delayed hypersensitivity in juvenile rheumatoid arthritis. Ann Rheum Dis (1973) 0.91
Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann Rheum Dis (1991) 0.87
Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor. Ann Rheum Dis (1976) 0.87
High levels of serum complement factors in juvenille rheumatoid arthritis. Ann Rheum Dis (1974) 0.84
IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions. Ann Rheum Dis (1974) 0.80
Antiglobulins in Nigerians with rheumatoid disease. Ann Rheum Dis (1975) 0.79
The visual prognosis in juvenile rheumatoid arthritis. Trans Am Ophthalmol Soc (1975) 0.79
Selective Subnormal IgG1 in 54 Adult Index Patients with Frequent or Severe Bacterial Respiratory Tract Infections. J Immunol Res (2016) 0.75
A direct binding assay for rheumatoid factor serum antiglobulins using fluorescein-labelled Fc fragment of human immunoglobulin-G. J Clin Pathol (1978) 0.75
Juvenile rheumatoid arthritis-a viral disease. Br Med J (1976) 0.75
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum (1977) 3.51
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med (1982) 3.40
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
A computer based intervention to reduce unnecessary serologic testing. J Rheumatol (1999) 2.37
Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis (2003) 2.33
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med (1997) 2.06
Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum (1994) 1.97
Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) (1981) 1.83
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1969) 1.79
Complement in human disease. Annu Rev Med (1968) 1.79
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum (1968) 1.72
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet (1970) 1.70
Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med (1973) 1.69
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med (1997) 1.66
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum (1983) 1.56
Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum (1972) 1.51
Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med (1995) 1.50
Hypocomplementemia in rheumatoid arthritis. Arthritis Rheum (1971) 1.48
Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann N Y Acad Sci (1969) 1.46
IgG subclasses--a review. Ann Allergy (1987) 1.45
Immunoglobulin subclasses in normal children. Pediatr Res (1979) 1.42
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.41
Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. Clin Exp Immunol (1974) 1.39
Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol (1997) 1.38
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. J Clin Invest (1976) 1.38
Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum (1979) 1.36
Human gamma-g subclasses. Prog Clin Immunol (1972) 1.35
A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest (1990) 1.35
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest (1985) 1.32
Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med (1973) 1.31
pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. J Immunol Methods (1979) 1.31
Rheumatoid arthritis associated with eosinophilia. Ann Intern Med (1971) 1.29
The gammaG subclass of antinuclear and antinucleic acid antibodies. Arthritis Rheum (1972) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology (2001) 1.27
Inherited deficiency of the sixth component of complement: a silent or null gene. J Immunol (1978) 1.27
Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis Rheum (1976) 1.26
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol (1974) 1.26
Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine. Arthritis Rheum (1976) 1.24
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Vasculitis associated with malignancy. Experience with 13 patients and literature review. Medicine (Baltimore) (1988) 1.22
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. Arthritis Rheum (1975) 1.21
Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum (1983) 1.21
Development of reticulum cell sarcoma during cyclophosphamide therapy. Arthritis Rheum (1974) 1.21
Diet therapy for rheumatoid arthritis. Arthritis Rheum (1983) 1.21
Weber-Christian disease. Analysis of 15 cases and review of the literature. Medicine (Baltimore) (1985) 1.20
Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases. J Exp Med (1971) 1.20
Re-examination of histocompatibility antigens found in patients with juvenile rheumatoid arthritis. N Engl J Med (1975) 1.20
Allopurinol hypersensitivity in a patient with severe, chronic, tophaceous gout. Arthritis Rheum (1985) 1.20
Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol (1975) 1.20
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum (1992) 1.19
Is running associated with degenerative joint disease? JAMA (1986) 1.18
Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med (1975) 1.17
Association of polyarthritis, subcutaneous nodules, and pancreatic disease. J Rheumatol (1975) 1.16
Spontaneous "autoimmune disease" in nude mice. J Immunol (1974) 1.16
The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid. Lab Invest (1970) 1.14
The complement system in rheumatoid synovitis. II. Intracytoplasmic inclusions of immunoglobulins and complement. Arthritis Rheum (1971) 1.13
Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1983) 1.13
Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med (1991) 1.13
Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med (1978) 1.11
Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Arthritis Rheum (1971) 1.10
A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum (1980) 1.10
Z-DNA-specific antibodies in human systemic lupus erythematosus. J Clin Invest (1983) 1.09
Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J Immunol (1982) 1.09
Immunofluorescent localization of double-stranded RNA in reovirus-infected cells. Virology (1970) 1.09
Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses (1988) 1.08
Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis. Ann Rheum Dis (1974) 1.08
Rheumatoid factor detection by nephelometry. Arthritis Rheum (1980) 1.07
The IgG subclasses of red cell antibodies and relationship to monocyte binding. Blood (1972) 1.07
Halothane and the liver: a review of the epidemiologic, immunologic and metabolic aspects of the relationship. Can J Surg (1972) 1.06
Food-induced (allergic) arthritis. Inflammatory arthritis exacerbated by milk. Arthritis Rheum (1986) 1.06
Radiographic findings in the hands in patients with systemic lupus erythematosus. Radiology (1978) 1.04
The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1984) 1.04